echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Just after the opening of September, the executive of this pharmaceutical company left!

    Just after the opening of September, the executive of this pharmaceutical company left!

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Under the market changes, executive changes have become the norm
    in the pharmaceutical industry.
    On the first day of September, a senior executive of a pharmaceutical company came to the news of
    his departure.
     

    Zhonghong Medical announced on September 1 that the board of directors of the company recently received a written resignation report from Mr.
    Cui Huijun, deputy general manager of the company, who applied for resignation as deputy general manager of the company because he had reached the statutory retirement age
    .
     

    The announcement said that Mr.
    Cui Huijun will no longer hold any position in the company after his resignation, and the work he is responsible for has been smoothly handed over, and his resignation will not have an impact on
    the company's production and operation.
     

    As of the date of this announcement, Mr.
    Cui Huijun does not directly hold the shares of the Company, and the shares of the Company held indirectly through Shanghai Luan Wei Trading Co.
    , Ltd.
    are implemented in accordance with the relevant regulations
    .

     

    Several executives changed
     
    Several executives changed
    It is understood that since the beginning of this year, a number of senior executives of Zhonghong Medical have changed
    .
    In addition to Mr.
    Cui Huijun, on April 14, the Company announced the change of directors and agreed to nominate Mr.
    Chen Jinming and Mr.
    Zeng Yuan as non-independent directors of the third board of directors of the company, and to nominate Mr.
    Zhang Xudong as an independent director of the third board of directors of the company; On January 7, the company announced that Mr.
    Chen Chun resigned from the company's general manager and other related positions
    due to personal work adjustment applications.

     

    According to the data, Zhonghong Medical has three major divisions: health protection division, safety infusion division and innovation incubation division, of which in the health protection division, it is mainly engaged in the research and development, production and sales
    of high-quality nitrile gloves, PVC gloves and other medical, industrial and daily disposable health protection gloves products.

     

    According to the 2021 annual report, Zhonghong Medical achieved an operating income of 4.
    909 billion yuan, an increase of 2.
    74% year-on-year; Net profit attributable to shareholders of listed companies was 2.
    342 billion yuan, down 12.
    07%
    year-on-year.
    According to the interim report, the company achieved a total operating income of 923 million yuan in the first half of 2022, down 74.
    7% year-on-year; Achieved a net profit attributable to the mother of 73.
    24 million yuan, down 96.
    5% year-on-year, due to the intensification of competition in the industry and the decline in
    market demand.

     

    Companies are looking for new high-growth businesses
     
    Companies are looking for new high-growth businesses
    The industry pointed out that Zhonghong Medical belongs to the A-share glove concept stock, before 2019, the company's attributable net profit was less than 100 million, with the change of the environment, the global demand for medical protection products increased, gloves brought performance explosion to the company, from 2020 to 2021, the company achieved attributable net profit of more than 2 billion yuan
    .
    However, with the increase in the number of enterprises entering the medical protection products, the fierce competition on the track, coupled with the decline in market demand, has brought a decline in
    the company's performance.

     

    From the change of profit indicators can also be seen in the company's operation, from 2019 to the first half of 2022, the company's gross profit margin was 18.
    85%, 70.
    83%, 61.
    70%, 18.
    32%; In the same period, the net profit margin was 7.
    81%, 55.
    74%, 47.
    70% and 18.
    32%
    respectively.

     

    In fact, not only Zhonghong Medical, A-share glove concept stocks in Yingke Medical and Lanfan Medical these head enterprises also experienced a "roller coaster", in the first half of this year, Yingke Medical achieved revenue of 3.
    74 billion yuan, down 64.
    96% year-on-year; Achieved attributable net profit of 402.
    3 million yuan, down 93.
    16% year-on-year; Blue Sail Medical's 2022 semi-annual report shows that the company's revenue in the first half of the year was about 2.
    574 billion yuan, a year-on-year decrease of 50.
    39%; Net loss was approximately $180 million, compared to a net profit of approximately $344 million for the same period last year
    .

     

    From the perspective of stock price performance, Zhonghong Medical rose 164% when it was listed, but then continued to fall, falling more than 74% in 17 months, and Yingke Medical and Lanfan Medical were also falling from the high point so far, falling by more than 85% and 71%
    respectively.

     

    The analysis believes that as the supply and demand of the medical glove market tend to balance, and the price of products falls, the glove protection industry dividend will disappear, and it is urgent to find new high-growth businesses
    for companies whose business relies heavily on single protective glove products.

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.